SCYNEXIS (SCYX)
(Real Time Quote from BATS)
$1.51 USD
-0.02 (-1.31%)
Updated Sep 25, 2024 12:24 PM ET
4-Sell of 5 4
D Value B Growth D Momentum C VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 35% (87 out of 252)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.58 | 9.99 |
Current Quarter Estimate | -0.20 | -1.06 | 61.00 |
Year Ago Quarter Estimate | -0.04 | -0.06 | 54.84 |
Next Quarter Estimate | 0.01 | -1.85 | 63.00 |
Next Year Estimate | 0.07 | 12.67 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -148.92 | 20.20 | 15.67 |
Next Year | 110.29 | 15.90 | 11.34 |
Last 5 Years | NA | 7.80 | 8.10 |
Next 5 Years | NA | 20.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -1.82 |
Price/Book (MRQ) | 0.96 | 1.65 |
Price/Cash Flow (MRFY) | 0.81 | 8.75 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -366.09% | -58.89% |
Return on Equity (TTM) | -57.41% | -58.88% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.